Japan Asia Investment

AMP offers financial advisory services such as M&A brokerage, overseas expansion, and business expansion based on the needs of the client.

KIC Holdings is a company focused on asset management and real estate investment, specializing in the management of distribution warehouses and related properties. The firm provides a range of services, including due diligence, acquisition, financing, management planning, and asset management, primarily targeting medium- to large-sized facilities. KIC Holdings operates both domestically in Japan and internationally, offering tailored financial products and advisory services to clients seeking to optimize their real estate investments. By leveraging industry expertise, the company aims to facilitate effective investment strategies and enhance asset value for its clientele.

Integral Geometry Science Inc. is a Japanese company founded in 2012, based in Kobe, that specializes in the design and development of advanced measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic fields and scattered fields, creating innovative solutions such as a microwave mammography system that effectively addresses the challenges of imaging high-density breast tissue. This technology provides clear images that aid healthcare professionals in accurately distinguishing between cancerous and non-cancerous tissue, significantly reducing the need for painful and radiation-exposing conventional screening methods. Additionally, Integral Geometry Science manufactures nondestructive inspection systems for lithium-ion batteries, further expanding its expertise in measurement systems.

Croco Corporation, founded in 2015 and based in Tokyo, Japan, specializes in web marketing and content solutions aimed at supporting global business initiatives. The company provides a comprehensive range of services, including current situation analysis, policy formulation, planning, production, editing, proofreading, and effect measurement. Utilizing advanced natural language processing technology, Croco is adept at understanding target users' search needs, extracting relevant keywords, and creating logical article content. This approach enables businesses to implement effective content marketing strategies and enhances their operational efficiency in the competitive marketplace. Additionally, Croco offers plagiarism check services and crowd sourcing, further diversifying its offerings in the digital marketing landscape.

Last One Mile Co Ltd specializes in facilitating connections between telecommunications facilities and customers. The company offers a comprehensive range of services, including the sale of new electronic power, gas, and internet connections. By providing essential infrastructure, Last One Mile aims to enhance connectivity and access to utilities for its clientele, ensuring efficient service delivery in a rapidly evolving technological landscape.

Yamap is an internet company focused on developing mobile applications tailored for mountain climbing and outdoor activities. The company's flagship application utilizes GPS technology to help users determine their location, even in areas without mobile phone service coverage. In addition to navigation, Yamap offers a variety of trekking-related products and services, enhancing the outdoor experience for mountaineers and trekkers. By combining advanced technology with a deep understanding of outdoor needs, Yamap supports enthusiasts in exploring and enjoying nature safely and effectively.

Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, the company specializes in developing innovative blood products, specifically platelets and red blood cells, from human induced pluripotent stem (iPS) cell lines. Megakaryon's technology focuses on transfusion medicine, enabling the production of platelets without reliance on traditional blood donations. This approach aims to enhance clinical applications and provide medical practitioners with the ability to manage and maintain patients' platelet counts effectively.

Nippon Souken Ltd. is a financial services agency based in Takamatsu, Japan, founded in 1996. The company specializes in providing insurance brokerage services and risk management solutions. Through its expertise, Nippon Souken aims to assist clients in navigating their insurance needs and managing potential risks effectively.

FacePeer, Inc. is a Tokyo-based company established in 2015, specializing in the development and operation of digital communication platforms. The company offers FaceHub, a web-based solution for face-to-face communications, and Viewhub, which focuses on facilitating online job interviews. By providing tailored solutions that adapt to various operating systems and challenges, FacePeer aims to enhance operational efficiency and transform workplace practices. Its platforms are designed to support business-to-business-to-customer interactions, contributing to the sustainable growth of organizations through effective online communication. Ultimately, FacePeer seeks to foster a connected society that promotes collective development and collaboration.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an additional office in San Francisco, California. Founded in 2006, the company specializes in the discovery and development of immune-regulatory therapeutics aimed at treating severe diseases and disorders related to the immune system. Utilizing its proprietary reVax technology, REGiMMUNE targets immune tolerance by inducing regulatory T cells, which can address a variety of conditions such as Graft versus Host Disease, type 1 diabetes, rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. The company has one clinical-stage compound, RGI-2001, currently in a Phase I/II trial for GvHD associated with hematopoietic stem cell transplantation, and a second product, RGI-3001, in preclinical development for type 1 diabetes. With a pipeline that includes several promising compounds, REGiMMUNE aims to provide innovative treatments that minimize the side effects commonly associated with traditional immunosuppressants.

Laxus Technologies operates an online fashion-sharing platform that specializes in the rental of designer handbags. The platform enables users to borrow high-end handbags for an unlimited duration, with the option for free replacements. This service allows women to access luxury fashion items in a cost-effective manner, catering to individual preferences and budgets. Through its application, Laxus Technologies facilitates seamless transactions, allowing consumers to acquire goods directly from sellers via a web browser or mobile app.

J-ARM is a medical laboratory that specializes in cell therapy and regenerative medicine, primarily aimed at treating illnesses in pets. The company develops various biotechnological products, including over ten types of immune cell culture kits designed specifically for dogs and cats. In addition to its product offerings, J-ARM provides consultation services related to cultured cells and safety testing. By focusing on advanced medical solutions, J-ARM aims to enhance the treatment options available to pet owners and veterinary hospitals, thereby improving the health and well-being of animals.

Wonderplanet Inc., established in 2012 and headquartered in Nagoya, Japan, specializes in the design and development of native language applications and games tailored for smartphones and tablets. The company creates both 2D and 3D games compatible with iOS and Android platforms.

Ligua Inc. is a consultancy firm specializing in management support services for the healthcare industry, headquartered in Osaka, Japan. Founded in 2004, the company offers a range of consulting services focused on sales office operations, including sales improvement, organizational management, executive education, and recruitment. In addition to these services, Ligua provides corporate management solutions such as management figures analysis and business plan development. The firm also offers problem-solving tools tailored for osteopaths, along with services in insurance agency and financial products brokerage, and medical expenses billing. Ligua aims to enhance the health and wellness sectors by facilitating genuine enrichment and happiness for individuals and businesses alike.

TORICO is a company based in Chisoda, Timis, founded in 2005. It operates an online platform and application that specializes in the sale of books, e-books, and manga-related products. The company is also involved in the planning, development, marketing, and sales of various goods related to manga and Japanese animation. TORICO's offerings include a comprehensive platform for comic enthusiasts, providing access to a wide range of manga and associated services.

Wonderleague is a manufacturer of VR and AR goggles and controllers intended to provide the best quality products and experiences.The company leverages technology to build AR and VR headsets and controllers available on ios and android devices and also develop an AR platform, enabling customers to have an interactive experience.

FacePeer, Inc. is a Tokyo-based company established in 2015, specializing in the development and operation of digital communication platforms. The company offers FaceHub, a web-based solution for face-to-face communications, and Viewhub, which focuses on facilitating online job interviews. By providing tailored solutions that adapt to various operating systems and challenges, FacePeer aims to enhance operational efficiency and transform workplace practices. Its platforms are designed to support business-to-business-to-customer interactions, contributing to the sustainable growth of organizations through effective online communication. Ultimately, FacePeer seeks to foster a connected society that promotes collective development and collaboration.

FunPep Co Ltd is a biotechnology company dedicated to the research and development of functional peptides, which are utilized in pharmaceuticals, cosmetics, and medical devices. The company primarily focuses on creating innovative treatments for intractable peptic ulcers and aims to produce next-generation pharmaceutical products, specifically through the use of antibody-inducing peptides. FunPep's portfolio includes a range of products, such as antibody drugs and pharmaceutical treatments, reflecting its commitment to advancing medical solutions and enhancing therapeutic options in the healthcare sector.

Aoi Co. is a Tokyo-based company that provides "Aoi Zemi," a free online lecture service designed for junior high and middle school students. The platform has successfully attracted over 3,000 users and boasts an impressive entrance exam passing rate of 86.3% for students aiming for their preferred universities. Aoi Co. is focused on enhancing its system development capabilities and plans to launch a learning state monitoring app for parents in September.

Eltes Co Ltd is a company based in Japan that specializes in big data analysis with a focus on risk detection. It offers consultation services that leverage digital risk technology to protect large databases and storage systems. Eltes provides internal fraud detection services aimed at preventing information security breaches caused by internal factors, as well as solutions for detecting and diagnosing security breaches stemming from external threats. Through its innovative approach to risk management, Eltes addresses critical security challenges for organizations by ensuring the integrity and safety of their data.

FunPep Co Ltd is a biotechnology company dedicated to the research and development of functional peptides, which are utilized in pharmaceuticals, cosmetics, and medical devices. The company primarily focuses on creating innovative treatments for intractable peptic ulcers and aims to produce next-generation pharmaceutical products, specifically through the use of antibody-inducing peptides. FunPep's portfolio includes a range of products, such as antibody drugs and pharmaceutical treatments, reflecting its commitment to advancing medical solutions and enhancing therapeutic options in the healthcare sector.

TMS Co., Ltd., established in 2005 and headquartered in Tokyo, Japan, is a clinical-stage biotechnology company. It specializes in developing drug candidates and medical technologies derived from academic research. TMS focuses on a unique group of small molecule compounds, known as SMTPs, which exhibit both thrombolytic and anti-inflammatory properties. The company's lead compound, TMS-007, is currently in a Phase IIa clinical trial for the treatment of acute ischemic stroke, in partnership with Biogen.

Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, the company specializes in developing innovative blood products, specifically platelets and red blood cells, from human induced pluripotent stem (iPS) cell lines. Megakaryon's technology focuses on transfusion medicine, enabling the production of platelets without reliance on traditional blood donations. This approach aims to enhance clinical applications and provide medical practitioners with the ability to manage and maintain patients' platelet counts effectively.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an additional office in San Francisco, California. Founded in 2006, the company specializes in the discovery and development of immune-regulatory therapeutics aimed at treating severe diseases and disorders related to the immune system. Utilizing its proprietary reVax technology, REGiMMUNE targets immune tolerance by inducing regulatory T cells, which can address a variety of conditions such as Graft versus Host Disease, type 1 diabetes, rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. The company has one clinical-stage compound, RGI-2001, currently in a Phase I/II trial for GvHD associated with hematopoietic stem cell transplantation, and a second product, RGI-3001, in preclinical development for type 1 diabetes. With a pipeline that includes several promising compounds, REGiMMUNE aims to provide innovative treatments that minimize the side effects commonly associated with traditional immunosuppressants.

JMC manufactures and sells prototypes, parts, and products using 3D printers, sand casting for industrial CT, and inspection and measurement services. They also provide 3D printer output, a CT biology encyclopedia, and 3DiH printer services.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an additional office in San Francisco, California. Founded in 2006, the company specializes in the discovery and development of immune-regulatory therapeutics aimed at treating severe diseases and disorders related to the immune system. Utilizing its proprietary reVax technology, REGiMMUNE targets immune tolerance by inducing regulatory T cells, which can address a variety of conditions such as Graft versus Host Disease, type 1 diabetes, rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. The company has one clinical-stage compound, RGI-2001, currently in a Phase I/II trial for GvHD associated with hematopoietic stem cell transplantation, and a second product, RGI-3001, in preclinical development for type 1 diabetes. With a pipeline that includes several promising compounds, REGiMMUNE aims to provide innovative treatments that minimize the side effects commonly associated with traditional immunosuppressants.

TMS Co., Ltd., established in 2005 and headquartered in Tokyo, Japan, is a clinical-stage biotechnology company. It specializes in developing drug candidates and medical technologies derived from academic research. TMS focuses on a unique group of small molecule compounds, known as SMTPs, which exhibit both thrombolytic and anti-inflammatory properties. The company's lead compound, TMS-007, is currently in a Phase IIa clinical trial for the treatment of acute ischemic stroke, in partnership with Biogen.

Rich Media offers media portal, web creation, and search engine optimization services.

BioAmber is a private company based in Delaware that specializes in the production of renewable succinic acid and related chemical intermediates. Formerly known as DNP Green Technology, the company rebranded following its acquisition of a joint venture with ARD. Utilizing a proprietary technology platform that integrates industrial biotechnology and chemical catalysis, BioAmber converts bio-based feedstocks into a variety of renewable chemicals. Its product offerings include materials for polyurethanes, resins, coatings, de-icing solutions, fine chemicals, lubricants, and engineering plastics, among others. The company aims to provide sustainable industrial chemical solutions to its clients, contributing to a more eco-friendly chemical industry.

Zibolan is a digital marketing company provides internet marketing and search engine optimisation.

Analogix Semiconductor, Inc. specializes in the design and manufacture of high-performance analog and mixed-signal semiconductor devices, primarily targeting the digital multimedia and communications markets. The company offers a range of products, including SlimPort solutions, timing controllers, and mobile display converters, which facilitate the transmission of high-quality video, audio, and data to various high-definition displays. Its product lineup includes the SlimPort ANX7688, a single-chip mobile transmitter capable of supporting 4K video resolution and high frame rates, catering to the needs of smartphones, tablets, and laptops. Founded in 2002 and headquartered in Santa Clara, California, Analogix also maintains offices in Beijing and Shenzhen, China, as well as locations in Taiwan, South Korea, and Japan, reinforcing its presence in the global semiconductor market.

Chiral Quest is a company specializing in the development and supply of intermediates essential for the production of innovative pharmaceuticals. With a focus on chiral catalysts, Chiral Quest leverages the extensive process development experience of its chemists to transform laboratory-scale processes into practical, scalable manufacturing solutions. The firm is dedicated to delivering high-quality drug intermediates, catering primarily to the global generic drug industry. Through its commitment to cost-effective manufacturing, Chiral Quest plays a vital role in enhancing the efficiency and effectiveness of drug production.

Palo Alto Networks is a California-based cybersecurity company that provides a comprehensive range of security solutions for organizations. The firm specializes in network security, cloud security, and security operations, making it a platform-based vendor in the cybersecurity space. With over 80,000 enterprise customers globally, Palo Alto Networks serves a significant portion of the Global 2000, demonstrating its prominent position in the industry. The company's offerings are designed to protect organizations from evolving cyber threats, ensuring robust security across various digital environments.

Sales Robotics Co., Ltd., founded in 2004 and based in Tokyo, Japan, specializes in developing and providing business support cloud services. The company focuses on building customer databases and sales pipelines, offering sales strategy consulting, and providing inside sales support. Additionally, it sells salesforce licenses and constructs sales support systems while also engaging in operation support and web system development projects. Sales Robotics also offers a service platform tailored for foreign language education, which includes language lessons alongside marketing and sales tools that facilitate data analysis and strategic sales preparation. Through these diverse offerings, the company aims to enhance operational efficiency and drive business growth for its clients.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an additional office in San Francisco, California. Founded in 2006, the company specializes in the discovery and development of immune-regulatory therapeutics aimed at treating severe diseases and disorders related to the immune system. Utilizing its proprietary reVax technology, REGiMMUNE targets immune tolerance by inducing regulatory T cells, which can address a variety of conditions such as Graft versus Host Disease, type 1 diabetes, rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. The company has one clinical-stage compound, RGI-2001, currently in a Phase I/II trial for GvHD associated with hematopoietic stem cell transplantation, and a second product, RGI-3001, in preclinical development for type 1 diabetes. With a pipeline that includes several promising compounds, REGiMMUNE aims to provide innovative treatments that minimize the side effects commonly associated with traditional immunosuppressants.

Chestnut Medical Technologies, Inc. specializes in the development of innovative minimally invasive therapies for Interventional Neuroradiology. The company is dedicated to creating technologies that enhance usability while improving patient outcomes and minimizing complications associated with neurovascular diseases. Among its notable products is the Alligator Retrieval Device, designed for the efficient retrieval and removal of foreign bodies from both peripheral and intracranial circulation. Through its advancements, Chestnut Medical aims to transform treatment approaches in the field of neurovascular intervention.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an additional office in San Francisco, California. Founded in 2006, the company specializes in the discovery and development of immune-regulatory therapeutics aimed at treating severe diseases and disorders related to the immune system. Utilizing its proprietary reVax technology, REGiMMUNE targets immune tolerance by inducing regulatory T cells, which can address a variety of conditions such as Graft versus Host Disease, type 1 diabetes, rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. The company has one clinical-stage compound, RGI-2001, currently in a Phase I/II trial for GvHD associated with hematopoietic stem cell transplantation, and a second product, RGI-3001, in preclinical development for type 1 diabetes. With a pipeline that includes several promising compounds, REGiMMUNE aims to provide innovative treatments that minimize the side effects commonly associated with traditional immunosuppressants.

Ecrio, Inc. is a technology company specializing in 4G LTE real-time communication software and services for the mobile industry. Based in Cupertino, California, Ecrio offers the Mobile Communications Client Suite (MCCS), which facilitates the deployment of core LTE services such as voice, video, and SMS, as well as rich communication services (RCS). The MCCS includes various components, such as SIP/IMS and VoLTE frameworks, designed to streamline the development of LTE and IMS-based messaging applications while ensuring interoperability with existing network infrastructure. Additionally, Ecrio provides a Device-Platform SDK for operators and device manufacturers to optimize installation and an Application Development SDK for creating communication-enhanced applications. The company's solutions cater to a diverse clientele, including handset manufacturers, mobile service operators, and infrastructure providers, helping them to deliver improved customer experiences and accelerate digital transformation through advanced communication capabilities. Founded in 1998, Ecrio remains dedicated to simplifying the integration of rich communication features across multiple applications and devices.

Moshimo Co., Ltd. is a Tokyo-based company founded in 2006, specializing in the planning and production of internet shopping sites. It enables small businesses to establish an online presence easily by providing a platform for building online storefronts. Moshimo offers drop shipping services, allowing businesses to sell products without the need to hold inventory or handle shipping logistics. This approach simplifies the process of online retail by letting wholesale suppliers manage inventory and delivery. With access to over 350,000 products from more than 800 suppliers, Moshimo supports small enterprises in efficiently managing their supply chains, thus facilitating their ability to sell merchandise online. The company operates as a subsidiary of Scroll 360 Corporation.

A privately held technology company headquartered in London.

Tudou Holdings is a prominent Chinese video sharing website that facilitates user engagement and creativity through its platform. Launched in 2005 by Wang Tei, Tudou allows users to watch, upload, rate, share, comment on, and recommend a variety of video content, including user-generated videos, licensed materials, and original programming. This interactive experience empowers young independent video producers to showcase their creativity. In 2012, Tudou merged with Youku, forming Youku Tudou, Inc., which became a leading entity in the online video sector in China. As of 2013, the platform attracted approximately 227 million unique monthly visitors, establishing a significant user base that outperformed major competitors in the industry.

All Ads is a Tokyo-based company that specializes in digital marketing services aimed at enhancing the cost-effectiveness of advertising for business professionals. The company focuses on lifetime value (LTV) marketing, integrating data, technology, and consulting to optimize advertising strategies. In addition to LTV marketing, All Ads provides in-house media management and licensing services, which encompass affiliate advertising consulting, operational advertising consulting, and roundtable discussions. The company's mission is to support the growth of advertisers by improving their advertising performance and overall business outcomes.

B.Creation offers digital services and development of smartphone application useful for fishing and outdoors. The company was established on March 29, 2004.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an additional office in San Francisco, California. Founded in 2006, the company specializes in the discovery and development of immune-regulatory therapeutics aimed at treating severe diseases and disorders related to the immune system. Utilizing its proprietary reVax technology, REGiMMUNE targets immune tolerance by inducing regulatory T cells, which can address a variety of conditions such as Graft versus Host Disease, type 1 diabetes, rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. The company has one clinical-stage compound, RGI-2001, currently in a Phase I/II trial for GvHD associated with hematopoietic stem cell transplantation, and a second product, RGI-3001, in preclinical development for type 1 diabetes. With a pipeline that includes several promising compounds, REGiMMUNE aims to provide innovative treatments that minimize the side effects commonly associated with traditional immunosuppressants.

BlogBus is a pioneering internet community service provider based in China, recognized as the first blog hosting service in the country. It stands out as the first commercial operator delivering paid services within the Chinese blogging sector. By offering a platform for users to create and manage their blogs, BlogBus has established a significant presence in the industry, contributing to the development and popularization of blogging in China. Its reputation as a leading service provider underscores its influence in the digital landscape, catering to a diverse range of users seeking to engage in online content creation and community building.

Broncus Medical is a medical technology company specializing in the development of minimally-invasive devices for treating lung diseases, including emphysema and lung cancer. Based in Mountain View, California, with an international presence in Nyon, Switzerland, Broncus is focused on addressing significant unmet medical needs in interventional pulmonology. The company is exploring its Exhale product line, which features a patented treatment method known as Airway Bypass, aimed at providing a minimally-invasive solution for patients suffering from homogeneous emphysema. Broncus is currently conducting the pivotal EASE Trial, enrolling patients worldwide to evaluate the efficacy of this treatment in severe cases of the disease. Additionally, Broncus offers a range of innovative products designed to enhance diagnostic and therapeutic outcomes in lung care, including the Archimedes System, LungPoint, and InterVapor System.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an additional office in San Francisco, California. Founded in 2006, the company specializes in the discovery and development of immune-regulatory therapeutics aimed at treating severe diseases and disorders related to the immune system. Utilizing its proprietary reVax technology, REGiMMUNE targets immune tolerance by inducing regulatory T cells, which can address a variety of conditions such as Graft versus Host Disease, type 1 diabetes, rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. The company has one clinical-stage compound, RGI-2001, currently in a Phase I/II trial for GvHD associated with hematopoietic stem cell transplantation, and a second product, RGI-3001, in preclinical development for type 1 diabetes. With a pipeline that includes several promising compounds, REGiMMUNE aims to provide innovative treatments that minimize the side effects commonly associated with traditional immunosuppressants.

Tixa Internet Technology Co., Ltd., headquartered in Beijing, is a leading provider of web-empowered products, systems, and services in China. The company specializes in contextual advertising solutions, catering to online advertisers and publishers. Tixa's offerings include NarrowAD, a targeted online advertising solution, and ChinaWi, an online corporate intelligence portal. The company also operates PRnews, a platform that facilitates the distribution of press releases to targeted media and key decision-makers. In addition to news delivery, Tixa provides media monitoring services, press release writing and translation, and crisis management services. Its multi-channel delivery network ensures real-time access to a diverse audience, including newspapers, wire services, and individual consumers. Tixa has established strategic alliances with prominent organizations such as Factiva, Bloomberg, and Reuters. Founded in 2000, the company was originally known as VeryE until it rebranded in 2004 following a significant financing round.

Azteq Mobile manufactures and markets mobile devices, palm tops, communication equipment, and handheld devices. The company is based in Walnut Creek, California.

SymBio Pharmaceuticals Limited is a biopharmaceutical company based in Tokyo, Japan, founded in 2005. It specializes in the research, development, manufacturing, and marketing of pharmaceutical drugs, primarily focusing on oncology and hematology. The company develops various anti-cancer agents, including Treakisym, an established treatment for non-Hodgkin's lymphoma, multiple myeloma, and chronic lymphocytic leukemia, which is currently undergoing Phase III clinical trials for relapsed/refractory diffuse large B-cell lymphoma. Additionally, SymBio is advancing several formulations, such as SyB L-1701—a ready-to-dilute formulation—and SyB L-1702, a rapid infusion formulation. Rigosertib, an oral preparation under development, is in Phase I clinical trials for solid tumors. SymBio is also working on SyB L-1101 and SyB C-1101 for higher-risk myelodysplastic syndromes, as well as SyB V-1901, an antiviral drug aimed at treating infectious diseases, and has operations across Japan, South Korea, China, Hong Kong, Taiwan, and Singapore.

CROOZ Inc., headquartered in Tokyo, Japan, is a technology company specializing in e-commerce infrastructure and social gaming applications. It offers a comprehensive EC system developed in-house, supporting mail-order operations, logistics, and HR solutions, driving volume growth, cost reduction, and profit generation for its clients. Additionally, CROOZ publishes and operates popular smartphone games in Japan and globally, with some titles grossing over US$1 million per month. The company also runs a fast fashion e-commerce platform, SHOPLIST.com, and a used fashion marketplace, SHOPLIST USED, along with a blog site, CROOZblog.

InPhase Technologies is a storage company focused on holographic data storage technology.

SMS is a Japanese company focused on providing information services tailored to the needs of an aging society. The company operates in multiple sectors, including nursing care, medical care, career development, healthcare, senior living, and international services. By catering to both business operators and end users, SMS aims to enhance the information infrastructure necessary for supporting the elderly and those involved in their care. Through its diverse offerings, SMS addresses the unique challenges and requirements of an aging population, facilitating access to essential services and information.

Magink Display Technologies Ltd. specializes in digital display technology, focusing on developing innovative solutions for the out-of-home media market. Founded in 2000 and headquartered in Mevasseret Zion, Israel, with additional offices in San Francisco and the United Kingdom, the company offers high-resolution digital ink display systems suitable for various applications, including outdoor advertising, retail signage, public information, transportation, and in-store promotional displays. By emphasizing energy efficiency and cost-effectiveness, Magink supplies its products to multiple sectors, particularly the casino industry, where its touch screen technology enhances gaming machines in casinos across the United States and Australia. The company is dedicated to the continuous advancement of its core technology, ensuring it meets the evolving needs of its diverse clientele through ongoing global deployments and testing of new product lines.

Beat Holdings Limited is a Hong Kong-based company that specializes in the development and distribution of blockchain technology applications and software products. Founded in 1999 and formerly known as Xinhua Holdings Limited, the company provides a range of services including mobile applications tailored for telecom and enterprise clients, as well as mobile messaging services. Beat Holdings also focuses on wellness services, healthcare, and the development of a blockchain ecosystem designed to manage mental and physical health data. The company engages in licensing intellectual property and operates in various Asian markets, including China and Japan, aiming to leverage its global network to facilitate business and investment opportunities.

istyle, Inc. is a company focused on the beauty industry, primarily known for its operation of the cosmetics portal website @cosme. The company manages various segments, including Media, Electronic Commerce, and Store. The Media segment provides a range of services, such as internet advertising, branding, and affiliate marketing. Through its Electronic Commerce segment, istyle engages in the buying and selling of cosmetics, quasi-drugs, and health foods via its online shopping platform. The Store segment is involved in planning and developing cosmetics retail categories, along with operating physical retail stores. Additionally, istyle has expanded its presence internationally, with subsidiaries in countries including Taiwan, China, Hong Kong, Malaysia, Singapore, Thailand, and the United States. The company also offers beauty-related services, including advertising, marketing, and research, as well as personnel dispatching and investment training services.

Rinat Neuroscience, established in 2001 as a spin-out from Genentech, specializes in the development of protein-based therapeutics targeting diseases and disorders of the nervous system. The company leverages over 15 years of research and development support from Genentech to advance its innovative pipeline. Rinat focuses on creating antibody drugs for various conditions, including pain, Alzheimer's disease, obesity, diabetes, and neuropathies. In addition to these therapeutic areas, Rinat is engaged in developing novel disease-modifying therapies aimed at modulating neuronal function and preventing or reversing damage to specific populations of neurons affected by these diseases.

Triage Medical Inc., an Irvine, Calif.-based developer orthopedic trauma devices.

Sosei Group Corporation is an international biopharmaceutical company based in Japan that focuses on discovering and developing innovative therapies for various medical conditions, including Alzheimer's disease, schizophrenia, cancer, migraine, addiction, and metabolic diseases. The company leverages advanced platform technologies, such as GPCR structure-based drug design, peptide platforms, and nanotechnology, to create a diverse product pipeline with significant therapeutic potential. Sosei Group has successfully partnered in the development and commercialization of three medicines, including two treatments for chronic obstructive pulmonary disease and an emergency contraceptive, which contribute to stable revenue streams and allow for continued growth in its operations.

InPhase Technologies is a storage company focused on holographic data storage technology.

Beenos Partners is a Tokyo-based venture capital firm founded in 1999, originally established as NetPrice.com, an eCommerce service provider. The company transitioned from its initial focus to a broader role in the startup ecosystem, offering incubation and support through its in-house team of experienced entrepreneurs and specialists. Beenos Partners aims to assist startups in various sectors, including information technology, online marketplaces, online payment, inbound tourism, entertainment, manufacturing, mobile, and enterprise software. The firm leverages its expertise in engineering, design, data science, and business management to help entrepreneurs develop and expand their businesses in a rapidly evolving market.

Magically, Inc. specializes in communication and collaboration technologies, catering primarily to the needs of personal and corporate users. The company offers a range of products designed to enhance information management and team collaboration, including its flagship product, MagicalDesk, which provides a suite of tools for small and medium enterprises. Its latest offering, Magical WorkSpace, focuses on streamlining workflow and fostering collaboration among teams. Additionally, Magically provides SmartSpace, a suite of personal information management applications, and Magical SyncServer, which facilitates mobile access to personal information across various devices. Established in 1998 and headquartered in Redwood City, California, Magically also has offices in Hong Kong, London, São Paulo, San Francisco, and Tokyo, emphasizing its commitment to serving a global, mobile workforce.

Silicon Wave is a San Diego-based company that specializes in Bluetooth wireless technology. It is recognized as a pioneer in this field and focuses on the design, development, and manufacturing of radio frequency integrated circuits. The company produces RF systems-on-chip that are utilized in various wireless and broadband communication applications. Through its innovative solutions, Silicon Wave contributes significantly to advancements in wireless communication technology.